SCHEMBL13875129

SCHEMBL13875129

CCC(O)CN1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
MAPT P10636 7/20 0.61
ATM Q13315 1/20 0.60
IGF1R P08069 1/20 0.59
ABCB1 P08183 6/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
LMNA P02545 2/20 0.59
TDP1 Q9NUW8 1/20 0.59
CACNA1G O43497 1/20 0.57
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
HTR1A P08908 1/20 0.56
DRD2 P14416 1/20 0.56
HTR7 P34969 1/20 0.56
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12781852 0.87 ADRA2A (0.71) MEN1KMT2AMAPTATMIGF1R
SCHEMBL19003697 0.84 MAPT (0.54) MEN1KMT2AMAPTATMIGF1R
SCHEMBL11728657 0.83 MAPT (0.57) MEN1KMT2AMAPTATMIGF1R
SCHEMBL8334018 0.82 MAPT (0.49) MEN1KMT2AMAPTATMIGF1R
SCHEMBL12535863 0.81 IGF1R (0.56) MEN1KMT2AMAPTATMIGF1R
SCHEMBL7903765 0.79 MAPT (0.67) MAPTSMN1; SMN2LMNATDP1
SCHEMBL31510201 0.77 TSHR (0.73) MEN1KMT2AMAPTATMABCB1
SCHEMBL2019905 0.77 MEN1 (0.78) MEN1KMT2AMAPTABCB1SMN1; SMN2
SCHEMBL2019901 0.77 MEN1 (0.78) MEN1KMT2AMAPTABCB1SMN1; SMN2
SCHEMBL2019903 0.77 MEN1 (0.78) MEN1KMT2AMAPTABCB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090093493-A1 1-PHENYLALCOXY-2-BETA-PHENYLETHYL DERIVATIVES AS P-GLYCOPROTEIN (P-GP) INHIBITORS USEFUL IN DRUG RESISTANCE EVENTS UNIVERSITA DI PISA, 40% (IT) 2009-04-09 US disclosed
US-20090093493-A1 1-PHENYLALCOXY-2-BETA-PHENYLETHYL DERIVATIVES AS P-GLYCOPROTEIN (P-GP) INHIBITORS USEFUL IN DRUG RESISTANCE EVENTS UNIVERSITA DI PISA, 40% (IT) 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093493-A1 1-PHENYLALCOXY-2-BETA-PHENYLETHYL DERIVATIVES AS P-GLYCOPROTEIN (P-GP) INHIBITORS USEFUL IN DRUG RESISTANCE EVENTS ABCB1, ABCC1, ABCC2 MEN1 4362/4885KMT2A 3964/4885MAPT 1077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.